메뉴 건너뛰기




Volumn 29, Issue 5, 1999, Pages 731-736

Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol

Author keywords

Elderly; Loading dose; Overanticoagulation; Warfarin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

EID: 0032707663     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb01623.x     Document Type: Article
Times cited : (53)

References (19)
  • 1
    • 0028786997 scopus 로고
    • Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range
    • 1. Hirsh J, Dalen JE, Deykin D, Pollen L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 1995; 108: 231S-3S.
    • (1995) Chest , vol.108
    • Hirsh, J.1    Dalen, J.E.2    Deykin, D.3    Pollen, L.4    Bussey, H.5
  • 2
    • 0029869807 scopus 로고    scopus 로고
    • Prevalence of atrial fibrillation with prior and new thromboembolic stroke in older patients
    • 2. Aronow WS, Ahn C, Gutstein H. Prevalence of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc 1996; 44: 521-3.
    • (1996) J Am Geriatr Soc , vol.44 , pp. 521-523
    • Aronow, W.S.1    Ahn, C.2    Gutstein, H.3
  • 7
    • 0021249057 scopus 로고
    • Flexible induction dose regimen for warfarin and prediction of maintenance dose
    • 7. Fennerty A, Dolben J, Thomas P et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J 1984; 288: 1268-70.
    • (1984) Br Med J , vol.288 , pp. 1268-1270
    • Fennerty, A.1    Dolben, J.2    Thomas, P.3
  • 8
    • 0018921310 scopus 로고
    • Evaluating patients warfarin requirements
    • 8. Jones BR, Baran A, Reidenberg M. Evaluating patients warfarin requirements. J Am Ger Soc 1980; 28: 10-2.
    • (1980) J Am Ger Soc , vol.28 , pp. 10-12
    • Jones, B.R.1    Baran, A.2    Reidenberg, M.3
  • 9
    • 0023726356 scopus 로고
    • The incidence, magnitude, and time course of the amiodarone-warfarin interaction
    • 9. Kerin NZ, Blevins RD, Goldman L, Faitel K, Rubenfire M. The incidence, magnitude, and time course of the amiodarone-warfarin interaction. Arch Intern Med 1988; 148: 1779-81.
    • (1988) Arch Intern Med , vol.148 , pp. 1779-1781
    • Kerin, N.Z.1    Blevins, R.D.2    Goldman, L.3    Faitel, K.4    Rubenfire, M.5
  • 10
    • 0023625745 scopus 로고
    • Atrial fibrillation: A major contributor to stroke in the elderly. The framingham study
    • 10. Wolf PA, Abbott RD, Kannel WD. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987; 147: 1561-4.
    • (1987) Arch Intern Med , vol.147 , pp. 1561-1564
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.D.3
  • 11
    • 0032521255 scopus 로고    scopus 로고
    • Warfarin anticoagulation and survival: A cohort analysis from the studies of left ventricular dysfunction
    • 11. Al-Khadra AS, Salem DN, Rand WM, Udelson JE, Smith JJ, Konstam MA. Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. JACC 1998; 31: 749-53.
    • (1998) JACC , vol.31 , pp. 749-753
    • Al-Khadra, A.S.1    Salem, D.N.2    Rand, W.M.3    Udelson, J.E.4    Smith, J.J.5    Konstam, M.A.6
  • 12
    • 0026176358 scopus 로고
    • Standardized initial warfarin treatment: Evaluation of initial response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response
    • 12. Doecke CJ, Cosh DG, Gallus AS. Standardized initial warfarin treatment: evaluation of initial response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response. Aust NZ J Med 1991; 21: 319-24.
    • (1991) Aust NZ J Med , vol.21 , pp. 319-324
    • Doecke, C.J.1    Cosh, D.G.2    Gallus, A.S.3
  • 13
    • 0029123928 scopus 로고
    • The influence of age, liver size and enantiomer concentrations on warfarin requirements
    • 13. Wynne H, Cope L, Kelly P, Whittingham T, Edwards C, Kamali F. The influence of age, liver size and enantiomer concentrations on warfarin requirements. Br J Clin Pharmacol 1995; 40: 203-7.
    • (1995) Br J Clin Pharmacol , vol.40 , pp. 203-207
    • Wynne, H.1    Cope, L.2    Kelly, P.3    Whittingham, T.4    Edwards, C.5    Kamali, F.6
  • 14
    • 0014730072 scopus 로고
    • Vitamin K deficiency in the elderly
    • 14. Hazell K, Baloch KH. Vitamin K deficiency in the elderly. Geront Clin 1970; 12: 10-7.
    • (1970) Geront Clin , vol.12 , pp. 10-17
    • Hazell, K.1    Baloch, K.H.2
  • 15
    • 0029564238 scopus 로고
    • Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirements in patients undergoing anticoagulation therapy
    • 15. Furuya H, Fernandez-Salguero P, Gregory W et al. Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirements in patients undergoing anticoagulation therapy. Pharmacogenetics 1995; 5: 389-92.
    • (1995) Pharmacogenetics , vol.5 , pp. 389-392
    • Furuya, H.1    Fernandez-Salguero, P.2    Gregory, W.3
  • 16
    • 0031854072 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic changes in the elderly
    • 16. Hammerlein A, Derendorf H, Lowenthal D. Pharmacokinetic and pharmacodynamic changes in the elderly. Clin Pharmacokinet 1998; 35: 49-64.
    • (1998) Clin Pharmacokinet , vol.35 , pp. 49-64
    • Hammerlein, A.1    Derendorf, H.2    Lowenthal, D.3
  • 19
    • 0009539352 scopus 로고
    • Warfarin sensitivity in the elderly
    • Crooks J, Stevenson IH (Eds). Baltimore: University Park Press
    • 19. Shepherd AMM, Wilson M, Stevenson IH. Warfarin sensitivity in the elderly. In: Crooks J, Stevenson IH (Eds). Drugs and the elderly. Baltimore: University Park Press, 1979.
    • (1979) Drugs and the Elderly
    • Shepherd, A.M.M.1    Wilson, M.2    Stevenson, I.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.